Jazz Pharma Reports Pro Forma Epidiolex Sales Grew 32% to $156 Million in Q2

New Cannabis Ventures
By NCV NewswireAug 3, 2021, 5:02 pm353 pts
Jazz Pharmaceuticals Announces Second Quarter 2021 Financial Results Closed GW Pharmaceuticals plc Acquisition, Creating an Innovative, High-Growth, Global Biopharma Leader 41% of Net Product Sales from Recently Launched or Acquired Products Strong Xywav™ Adoption with 5,100 Active Patients Exiting the Second…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

A Gen Zer’s Favorite 7 Trippy Movie Scenes 78

Cannabis Stocks Are Soaring 76

MOTA Fuels the American Glass Revolution 75

Marijuana MSO TerrAscend completes $79 million in debt financing 73

Pennsylvania Could Be 25th State to Legalize Adult-Use Cannabis Under New Bill 45

Texas Governor Calls Hemp Products ‘Lawful Agricultural Commodity’ in Special Session Notice 42

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.